MIFH
HAE icon

Migdal Insurance & Financial Holdings’s Haemonetics HAE Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,662
Closed -$266K – 722
2018
Q4 		$266K Buy
+2,662
New +$280K 0.01% 328

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Migdal Insurance & Financial Holdings's HAE Position: Q1 2019 in Review

Migdal Insurance & Financial Holdings sold out of Haemonetics (HAE) in Q1 2019, closing a stake of 2,662 shares — an estimated $266K sold.

Migdal Insurance & Financial Holdings first reported a position in HAE in Q4 2018 and held it in 1 quarter. The position peaked at $266K in Q4 2018. 260 funds tracked by Wall St. Rank hold HAE as of Q1 2019.

  • Migdal Insurance & Financial Holdings reported no remaining Haemonetics position as of Q1 2019 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 2,662 Haemonetics shares in Q1 2019, an estimated $266K.
  • Migdal Insurance & Financial Holdings first reported a position in Haemonetics in Q4 2018 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's Haemonetics position peaked at $266K in Q4 2018.
  • 260 funds tracked by Wall St. Rank held Haemonetics as of Q1 2019.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2019, filed 1 May 2019.